advertisement
Clinical Ophthalmology 47
Showing records 1 to 25 | Display all abstracts in Clinical Ophthalmology67185 Effect of preservative removal from fixed-combination bimatoprost/timolol on intraocular pressure lowering: a potential timolol dose-response phenomenon
Shen J
Clinical Ophthalmology 2016; 10: 373-383
67463 In vitro mitomycin C absorption and delivery with different sponge materials used in filtering surgery
Urbaneja D
Clinical Ophthalmology 2016; 10: 665-669
67518 Omega-3 fatty acid supplementation improves dry eye symptoms in patients with glaucoma: results of a prospective multicenter study
Tellez-Vazquez J
Clinical Ophthalmology 2016; 10: 617-626
66654 Measurement of central corneal thickness by ultrasonic pachymeter and oculus pentacam in patients with well-controlled glaucoma: hospital-based comparative study
Rashid RF
Clinical Ophthalmology 2016; 10: 359-364
66767 Comparison between the EX-PRESS P-50 implant and trabeculectomy in patients with open-angle glaucoma
Mendoza-Mendieta ME
Clinical Ophthalmology 2016; 10: 269-276
67145 Efficacy and tolerability of brinzolamide/brimonidine suspension and prostaglandin analogs in patients previously treated with dorzolamide/timolol solution and prostaglandin analogs
Lo JS
Clinical Ophthalmology 2016; 10: 583-586
67443 Feasibility study of sustained-release travoprost punctum plug for intraocular pressure reduction in an Asian population
Perera SA
Clinical Ophthalmology 2016; 10: 757-764
67517 A combined analysis of four observational studies evaluating the intraocular pressure-lowering ability and tolerability of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension
Stevens A
Clinical Ophthalmology 2016; 10: 635-641
67174 Corneal biomechanics in asymmetrical normal-tension glaucoma
Helmy H
Clinical Ophthalmology 2016; 10: 503-510
67184 Benefits of switching from latanoprost to preservative-free tafluprost eye drops: a meta-analysis of two Phase IIIb clinical trials
Uusitalo H
Clinical Ophthalmology 2016; 10: 445-454
66695 Review of external ocular compression: clinical applications of the ocular pressure estimator
Korenfeld MS
Clinical Ophthalmology 2016; 10: 343-357
67146 Risk factors for tube exposure as a late complication of glaucoma drainage implant surgery
Chaku M
Clinical Ophthalmology 2016; 10: 547-553
66720 Teleophthalmology: improving patient outcomes?
Sreelatha OK
Clinical Ophthalmology 2016; 10: 285-295
67145 Efficacy and tolerability of brinzolamide/brimonidine suspension and prostaglandin analogs in patients previously treated with dorzolamide/timolol solution and prostaglandin analogs
Pang PM
Clinical Ophthalmology 2016; 10: 583-586
67146 Risk factors for tube exposure as a late complication of glaucoma drainage implant surgery
Netland PA
Clinical Ophthalmology 2016; 10: 547-553
67174 Corneal biomechanics in asymmetrical normal-tension glaucoma
Leila M
Clinical Ophthalmology 2016; 10: 503-510
67443 Feasibility study of sustained-release travoprost punctum plug for intraocular pressure reduction in an Asian population
Ting DS
Clinical Ophthalmology 2016; 10: 757-764
66720 Teleophthalmology: improving patient outcomes?
Ramesh SV
Clinical Ophthalmology 2016; 10: 285-295
66654 Measurement of central corneal thickness by ultrasonic pachymeter and oculus pentacam in patients with well-controlled glaucoma: hospital-based comparative study
Farhood QK
Clinical Ophthalmology 2016; 10: 359-364
67463 In vitro mitomycin C absorption and delivery with different sponge materials used in filtering surgery
Morilla-Grasa A
Clinical Ophthalmology 2016; 10: 665-669
66767 Comparison between the EX-PRESS P-50 implant and trabeculectomy in patients with open-angle glaucoma
López-Venegas AP
Clinical Ophthalmology 2016; 10: 269-276
67184 Benefits of switching from latanoprost to preservative-free tafluprost eye drops: a meta-analysis of two Phase IIIb clinical trials
Egorov E
Clinical Ophthalmology 2016; 10: 445-454
67185 Effect of preservative removal from fixed-combination bimatoprost/timolol on intraocular pressure lowering: a potential timolol dose-response phenomenon
Bejanian M
Clinical Ophthalmology 2016; 10: 373-383
67517 A combined analysis of four observational studies evaluating the intraocular pressure-lowering ability and tolerability of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension
Iliev ME
Clinical Ophthalmology 2016; 10: 635-641
66695 Review of external ocular compression: clinical applications of the ocular pressure estimator
Dueker DK
Clinical Ophthalmology 2016; 10: 343-357